A Burns

Latest

• Comprehensive genome-wide analysis of CLL samples from UK 1st line and relapsed/refractory clinical trials
• Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia